Triangle Neuropsychiatry
Durham, North Carolina, United States
Psychiatrist in Durham, North Carolina
3713 University Dr # B, Durham, NC 27707
About Triangle Neuropsychiatry
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Triangle Neuropsychiatry
During the past decade, Triangle Neuropsychiatry conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
1996-11-01
2010-12-01
Completed
77
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
2001-10-01
2004-04-01
Completed
190
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
2001-12-01
2014-10-01
Completed
480
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Triangle Neuropsychiatry" #1 sponsor was "Shire" with 10 trials, followed by "Noven Therapeutics" with 2 trials
sponsored, "Cephalon" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Sunovion"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Triangle Neuropsychiatry
According to Clinical.Site data, the most researched conditions in "Triangle Neuropsychiatry" are
"ADHD" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "Attention-Deficit/Hyperactivity Disorder" (2 trials), "ADHD Specifically With Executive Function Impairment" (1 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Triangle Neuropsychiatry" in a lesser frequency.
Clinical Trials Intervention Types at Triangle Neuropsychiatry
Most popular intervention types in "Triangle Neuropsychiatry" are "Drug" (15 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Extended-release Guanfacine Hydrochloride" (2 trials), "SHP465" (2 trials), "Aripiprazole" (1 trials) and "Atomoxetine Hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Triangle Neuropsychiatry
The vast majority of trials in "Triangle Neuropsychiatry" are
15 trials for "All" genders.
Clinical Trials Status at Triangle Neuropsychiatry
Currently, there are NaN active trials in "Triangle Neuropsychiatry".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Triangle Neuropsychiatry,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Triangle Neuropsychiatry, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".